MDPV: Difference between revisions
No edit summary |
m (fixed title of table) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
[[File:MDPV.png|250px|right]] | [[File:MDPV.png|250px|right]] | ||
Methylenedioxypyrovalerone (MDPV) is a potent, synthetic euphoric stimulant, which shares some of the empathogenic effects of MDMA and acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). It is known for its tendency to cause compulsive redosing and some users report sexual arousal. MDPV (together with Methylone and Mephedrone) is one of the first substances that have been found in products sold as "bath salts", "plant food/fertilizer", and in some "ecstasy" pills. | '''Methylenedioxypyrovalerone''' (MDPV) is a potent, synthetic euphoric stimulant, which shares some of the empathogenic effects of MDMA and acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). It is known for its tendency to cause compulsive redosing and some users report sexual arousal. MDPV (together with Methylone and Mephedrone) is one of the first substances that have been found in products sold as "bath salts", "plant food/fertilizer", and in some "ecstasy" pills. | ||
= History = | == History == | ||
MDPV was first developed in the 1960s by a team at Boehringer Ingelheim. It remained an obscure stimulant until around 2004 when it was reportedly sold as a designer drug. Products labeled as bath salts containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing for Spice and K2 as incense. | MDPV was first developed in the 1960s by a team at Boehringer Ingelheim. It remained an obscure stimulant until around 2004 when it was reportedly sold as a designer drug. Products labeled as bath salts containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing for Spice and K2 as incense. | ||
= Dosage = | == Dosage == | ||
== Oral == | === Oral === | ||
{| class="wikitable" | {| class="wikitable" | ||
| Line 33: | Line 33: | ||
|} | |} | ||
== Insufflated == | === Insufflated === | ||
{| class="wikitable" | {| class="wikitable" | ||
| Line 55: | Line 55: | ||
|} | |} | ||
= Duration = | == Duration == | ||
== Oral == | === Oral === | ||
{| class="wikitable" | {| class="wikitable" | ||
| Line 89: | Line 89: | ||
|} | |} | ||
== Insufflated == | === Insufflated === | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ Insufflated | ||
|- | |- | ||
| Line 121: | Line 121: | ||
|} | |} | ||
= Effects = | == Effects == | ||
== Postive == | === Postive === | ||
* Stimulation (mental and physical) | * Stimulation (mental and physical) | ||
| Line 141: | Line 141: | ||
* Sexual arousal | * Sexual arousal | ||
== Neutral == | === Neutral === | ||
* Stimulation (mental and physical) | * Stimulation (mental and physical) | ||
| Line 147: | Line 147: | ||
* Mild elevation in heart rate | * Mild elevation in heart rate | ||
== Negative == | === Negative === | ||
Llikelihood of negative side effects increases with higher doses. | Llikelihood of negative side effects increases with higher doses. | ||
| Line 183: | Line 183: | ||
* Hallucinations & psychotic behavior (at high doses or with repeated use) | * Hallucinations & psychotic behavior (at high doses or with repeated use) | ||
= Harm Reduction = | == Harm Reduction == | ||
* Avoid driving and operating heavy machinery | * Avoid driving and operating heavy machinery | ||
| Line 189: | Line 189: | ||
* Recommended time (pauses) between using the substance | * Recommended time (pauses) between using the substance | ||
= Chemistry and Pharmacology = | == Chemistry and Pharmacology == | ||
Systematic name: (RS)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | Systematic name: (RS)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | ||
| Line 195: | Line 195: | ||
MDPV is the 3,4-methylenedioxy ring-substituted analog of the compound pyrovalerone, developed in the 1960s, which has been used for the treatment of chronic fatigue and as an anorectic, but caused problems of abuse and dependence. However, despite its structural similarity, the effects of MDPV bear little resemblance to other methylenedioxy phenylalkylamine derivatives such as 3,4-methylenedioxy-N-methylamphetamine (MDMA), instead producing primarily stimulant effects with only mild entactogenic qualities. | MDPV is the 3,4-methylenedioxy ring-substituted analog of the compound pyrovalerone, developed in the 1960s, which has been used for the treatment of chronic fatigue and as an anorectic, but caused problems of abuse and dependence. However, despite its structural similarity, the effects of MDPV bear little resemblance to other methylenedioxy phenylalkylamine derivatives such as 3,4-methylenedioxy-N-methylamphetamine (MDMA), instead producing primarily stimulant effects with only mild entactogenic qualities. | ||
= Legal status= | == Legal status == | ||
MDPV is currently in Schedule I in the United States. This means it is illegal to manufacture, buy, possess, or distribute (sell, trade or give) without a DEA license. | MDPV is currently in Schedule I in the United States. This means it is illegal to manufacture, buy, possess, or distribute (sell, trade or give) without a DEA license. | ||
| Line 201: | Line 201: | ||
MDPV is also illegal in Australia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Hungary, Israel, Sweden and the UK. | MDPV is also illegal in Australia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Hungary, Israel, Sweden and the UK. | ||
= Links = | == Links == | ||
[https://en.wikipedia.org/wiki/MDPV Wikipedia] | [https://en.wikipedia.org/wiki/MDPV Wikipedia] | ||
| Line 210: | Line 210: | ||
[[Category:Stimulant]] | [[Category:Stimulant]] | ||
[[Category:Research Chemical]] | |||
Latest revision as of 14:48, 21 October 2018
Methylenedioxypyrovalerone (MDPV) is a potent, synthetic euphoric stimulant, which shares some of the empathogenic effects of MDMA and acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). It is known for its tendency to cause compulsive redosing and some users report sexual arousal. MDPV (together with Methylone and Mephedrone) is one of the first substances that have been found in products sold as "bath salts", "plant food/fertilizer", and in some "ecstasy" pills.
History
MDPV was first developed in the 1960s by a team at Boehringer Ingelheim. It remained an obscure stimulant until around 2004 when it was reportedly sold as a designer drug. Products labeled as bath salts containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing for Spice and K2 as incense.
Dosage
Oral
| Light | 4-10 mg |
| Common | 8-15 mg |
| Strong | 12-25 mg |
| Heavy | >25 mg |
Insufflated
| Light | 2-5 mg |
| Common | 5-11 mg |
| Strong | 10-20 mg |
| Heavy | >20 mg |
Duration
Oral
| Onset | 15-30 minutes |
| Coming-up | 30-60 minutes |
| Peak | 30-180 minutes |
| Coming-down | 30-120 minutes |
| Total duration | 2-7 hours |
| After-effects | 2-48 hours |
Insufflated
| Onset | 5-20 minutes |
| Coming-up | 15-30 minutes |
| Peak | 30-120 minutes |
| Coming-down | 30-60 minutes |
| Total duration | 2-3.5 hours |
| After-effects | 2-48 hours |
Effects
Postive
- Stimulation (mental and physical)
- Euphoria, mood lift
- Increased sociability & talkativeness
- Increased productivity and motivation
- Increased mental clarity
- Enhanced creativity
- Feelings of empathy
- Sexual arousal
Neutral
- Stimulation (mental and physical)
- Mild elevation in heart rate
Negative
Llikelihood of negative side effects increases with higher doses.
- Tightened jaw muscles, grinding teeth (trismus and bruxia)
- Reduced enjoyment of eating & loss of appetite
- Disturbed sleep patterns
- Involuntary body movements (twitching, lip-smacking, etc.)
- Confusion and/or scrambled thoughts
- Gastrointestinal disturbance
- Muscle tension
- Residual depressed mood
- Nystagmus & eye spasm
- Anxiousness & nervousness & paranoia
- Harsh comedown effects
- Fiending (redosing repeatedly without planning to do so)
- Excessive excitation & hyperactivity
- Headache
- Very elevated heart rate
- Hallucinations & psychotic behavior (at high doses or with repeated use)
Harm Reduction
- Avoid driving and operating heavy machinery
- Recommended time (pauses) between using the substance
Chemistry and Pharmacology
Systematic name: (RS)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
MDPV is the 3,4-methylenedioxy ring-substituted analog of the compound pyrovalerone, developed in the 1960s, which has been used for the treatment of chronic fatigue and as an anorectic, but caused problems of abuse and dependence. However, despite its structural similarity, the effects of MDPV bear little resemblance to other methylenedioxy phenylalkylamine derivatives such as 3,4-methylenedioxy-N-methylamphetamine (MDMA), instead producing primarily stimulant effects with only mild entactogenic qualities.
Legal status
MDPV is currently in Schedule I in the United States. This means it is illegal to manufacture, buy, possess, or distribute (sell, trade or give) without a DEA license.
MDPV is also illegal in Australia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Hungary, Israel, Sweden and the UK.